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requiring medical assistance (DC= 6.0, DT= 5.9), HE requiring non-medical assistance 
(DC= 5.9, DT= 5.9), other HE not requiring assistance (DT= 5.7), and treatment goals 
not being met (DC= 5.6). Compared to current users, DT and DC patients were more 
likely to have experienced ≥ 1 HE in the previous year (DC= 41.0%, DT= 43.1% vs. 
current= 8.8%; p< .05), and experienced a greater mean number of events per year 
(DC= 1.59, DT= 1.47 vs. current= 0.24, p< .05). Having ≥ 1 HE requiring medical assis-
tance in the previous year was more common among DC patients than DT or current 
patients (DC= 7.4%, DT= 4.3%, current= 4.8%; p< .05). CONCLUSIONS: Hypoglycemia 
and glycemic control emerged as the most important concerns physicians have 
when deciding to DC or DT SU therapy. DC and DT patients were more likely to have 
experienced HE, and with greater severity, than current SU patients.
PDB100
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OBJECTIVES: While change in glycated hemoglobin (A1C) is typically used as the 
primary measure of efficacy in clinical trials of diabetes medications, quality of care 
in “real-world” clinical practice is often assessed based on attainment of patient-
specific A1C targets, as recommended in HEDIS 2014 performance benchmarks by 
the National Committee for Quality Assurance. HEDIS measures are used by US 
health plans to measure care and service performance. To assist in the design of 
pragmatic clinical trials for new insulin glargine 300 U/ml (Gla-300), we estimated 
A1C targets for T2DM patients initiating basal insulin in real-world clinical prac-
tice, using a large retrospective database and data from a clinical trial. METHODS: 
Insulin-naïve T2DM patients initiating basal insulin were identified in both the 
Ingenix Impact National Managed Care (IMPACT) database (n= 22,428) and EDITION 
3 (n= 862), a clinical trial of Gla-300. Patients were stratified according to whether 
they were aged < 65y and free of selected comorbidities (A1C target < 7.0%), or aged 
≥ 65y and/or with one or more comorbidities (A1C target < 8.0%), according to HEDIS 
measures. RESULTS: In the IMPACT database, mean age was 52y, and mean baseline 
A1C (SD) was 9.0% (±2.7) in those with available A1C. Patients aged < 65y without 
comorbidities (target < 7.0%) constituted 68.1% of the sample, while 31.9% were 
aged ≥ 65y and/or had comorbidities (target < 8.0%). In the EDITION 3 trial, mean age 
was 58y, and mean baseline A1C (SD) was 8.5% (±1.1). Patients aged < 65y without 
comorbidities (target < 7.0%) constituted 73.0%, and 27.0% were aged ≥ 65y and/or 
had comorbidities (target < 8.0%). CONCLUSIONS: The distribution of T2DM patients 
initiating basal insulin by A1C target, based on HEDIS performance measures, was 
similar in both real-world and clinical trial settings. Findings from trials therefore 
may be useful in the design of pragmatic clinical trials of Gla-300.
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OBJECTIVES: The aim of the study was to measure the effect of diabetes educational 
program on type 2 diabetic patients. METHODS: In total, a convenient sample of 
215 patients were attended a group-based educational intervention session about 
diabetes which is conducted by a researcher. Knowledge evaluation questionnaire 
were evaluated at pre and post test. Anthropometric measurements and lab tests 
were measured at pre and post test. Significance of the results was assessed by 
paired t- test at 95% confidence interval using SPSS version 16. RESULTS: BMI was 
decreased significantly after educational intervention, (from 32.1±5.76 to 31.23±5.8) 
(p = 0.000). Moreover, a significant decrease in glycosylated hemoglobin after edu-
cational intervention were reported, (from 8.57± 1.21 to 7.95±1.42) (p = 0.000).A sig-
nificant increase in knowledge evaluation test scores were shown after educational 
intervention (from 60.6±20.65 increased to 78.1±13.4) (p = 0.000). CONCLUSIONS: 
Diabetes education is a cornerstone in the management and care of diabetes and 
should be an integral part of health planning involving patient’s family, diabetes 
care team, community and decision makers in the education process.Key words 
Diabetes, Educational, Program, Intervention.
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OBJECTIVES: It is important to understand diabetes treatment patterns over time. 
This study compared changes in comorbidities, treatment patterns, and costs 
among newly-diagnosed T2D patients in 2007 and 2012. METHODS: Separate 
cross-sectional analyses of medical treatments, diagnoses, and pharmacy claims 
in the Truven Health MarketScan® Database were conducted for 2007 and 2012. 
Criteria for newly-diagnosed T2D were enrolment 6 months prior to index, ≥ 2 
diagnoses for T2D (ICD-9 codes), ≥ 18 years old, and continuous enrolment in 
a plan with prescription benefits for ≥ 1 year. RESULTS: Comparing 2007 with 
2012, T2D incidence rate decreased from 1.1% to 0.65% of all enrolled patients. 
Hyperlipidemia (46% and 57%) and hypertension (55 % and 62%) were the 2 most 
prevalent comorbidities. 46% and 57% of patients in 2007 and 2012 used only oral 
anti-diabetic drugs (OADs). Single OAD use increased from 68% to 77% of these 
patients. Metformin (Met) was the most prevalent OAD monotherapy, amounting 
to 75% and 90% of single OAD prescriptions. SU monotherapy fell from 14% to 6%. 
Met+SU, the most widely used dual OAD combination, grew from 48% to 57% of 
dual users. Met+TZD use fell from 30% to 0%, replaced by Met+DPP-IV (34%). An 
insulin-only regimen was used by 1.4% and 1.6% of patients for 2007 and 2012, 
and insulin+OADs were used by 2.5% and 3.7% of patients, respectively. Basal 
HealthCoin ≥ PCure - EINMBNE, Private , where INMBMedicare is the incremental 
net monetary benefits (INMB) to Medicare of a cure of diabetes for a 65-years old, 
EINMBNE, Private is the average INMB to the private payer for a cure of diabetes 
across all non-elderly incident population with diabetes, and PCureis the market 
price for the cure. Using empirical estimates, we explore whether a developing 
such a HealthCoin would be feasible. CONCLUSIONS: We find, theoretically, that 
developing such a HealthCoin may be feasible for a cure of diabetes. Extension of 
this work would explore how such HealthCoins can be traded within the private 
sector and also in other disease areas.
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OBJECTIVES: Women with Gestational Diabetes Mellitus (GDM) have six times higher 
risk of developing Diabetes Mellitus (DM) type 2 compared to women who don’t have 
GDM. The purpose of this study was to evaluate the protective effects of breast-feeding 
on development of DM in women with GDM. METHODS: This was a cross sectional 
study where a secondary database analysis was done using National Health and 
Nutrition Examination Survey (NHANES) data 2007-2008, 2009-2010 and 2011-2012. 
Females 20 to 75 years with at least one live birth were included. Chi-square-test 
compared differences between categorical variables and t-test examined differences 
in the means for continuous variables. Unadjusted-odds-ratio was calculated using 
logistic regression to examine breastfeeding as an effect modifier in the association 
between GDM and DM. Model was adjusted for age, BMI, race/ethnicity, income, edu-
cation, age at DM and number of live births. Sample weights and the stratification 
and clustering of the design were incorporated to obtain proper estimates. RESULTS: 
The final analytic sample consisted of 6503 participants. Percentage of GDM women 
who breast-fed seemed higher than women without GDM (64.6 % vs. 44.9%). Among 
women who breastfed, the odds ratio for developing DM in women with GDM was 
3.3 (95% CI 2.3, 4.9) compared to those without GDM while, in women who never 
breastfed, the odds ratio was 3.9 (95% CI 2.3, 6.6). After adjusting for age, BMI, race/
ethnicity, education and number of live births, OR for the association between DM and 
GDM was 2.2 (1.4, 3.4) in women who breastfed and 2.8 (1.6, 4.9) in women who didn’t 
breast feed. CONCLUSIONS: This analysis found that there’s potential benefit of BF 
in the prevention of DM among women who had GDM. This result adds to the already 
known important benefits of BF and more women should be encouraged to BF.
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OBJECTIVES: Most endocrine disorders are chronic diseases that need life-long 
care. Some of the most common endocrine diseases include diabetes mellitus, 
hypothyroidism and metabolic syndrome. Although most of the patients suffering 
of these diseases are followed by their primary care physician, definite diagno-
sis, initiation/change of treatment and chronic care of the disease is ensured by 
the endocrinologist. The objective of this study was to evaluate an endocrinolo-
gist electronic medical record (EMR) database to assess its feasibility for use in 
observational studies. METHODS: We analyzed de-identified patient data from 
Longitudinal Patient Database (LPD) Endocrinologist panel, including endocrinolo-
gists from 2013-2014. Comprehensiveness and completeness of each variable by 
visit was evaluated. Characteristics of physicians and patient population were 
compared to published sources. RESULTS: There were 77 243 visits by 34 492 active 
patients (= 1 visit per year) to 40 physicians. Completeness of each variable by visit 
ranked from 100% to 27% for sex, age and laboratory results. Most of these patients 
(73%) were female. Analysis of diagnosis associated to visits revealed that 32 % 
were related to diabetes, while 32% and 9% were related to thyroid disorders and 
obesity respectively. Among diabetic patients, 50% were female, and 74% had type 
2 diabetes. An average BMI of 30 and HbA1C of 7.4% was recorded. Among treated 
patients 38% received sulfonylureas and 59 % biguanides. A third of the patients 
(34%) received one, another third (33%) received two, and another third (33%) three 
or more anti-diabetic treatments (including insulin). Insulin was prescribed, alone 
or in combination, in 36% of cases. The comparison of these data with literature 
is presented. CONCLUSIONS: This panel is still new and needs further validation 
studies. Good agreement with published data suggests this may be a valuable tool 
to support observational studies.
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OBJECTIVES: Sulfonylureas (SU) are a widely-prescribed class of oral medications 
used to treat type 2 diabetes mellitus and are known to cause hypoglycemic events 
(HE) and weight gain. In this survey, we aimed to identify reasons reported by physi-
cians for discontinuing (DC) or down-titrating (DT) SU therapy. METHODS: Primary 
care physicians (PCPs) and specialists (endocrinologists and diabetologists) were 
recruited from the AllGlobal panel, an actively managed, double opt-in panel of 
physicians. Participants were asked to rate their level of concern regarding potential 
reasons for DC or DT on a 7-point Likert scale (1= not at all concerned, 7= extremely 
concerned). In addition, physicians reviewed one chart each from a typical SU 
patient with DC or DT in the previous 6 months and 2 current SU patients without 
DC or DT in the previous 6 months to collect patient characteristics and medical 
history. RESULTS: 776 PCPs and 250 specialists participated, of whom 76% were 
male and 93% were aged 35 to 64. Physicians reported highest concern about HE 
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OBJECTIVES: Diagnosis related groups (DRG) like financing method was introduced 
in Hungary in 1993 for acute care hospital reimbursement. Due to the increased 
activity of the hospitals, an upper ceiling, the so called performance volume limit 
(PVL) was introduced in acute care hospital financing in 2006. The aim of our study 
was to analyze the effect of performance volume limit on DRG based hospital financ-
ing on the example of a Hungarian tertiary teaching hospital, the Clinical Centre 
of the University of Pécs. METHODS: Data derived from the financial database of 
the National Health Insurance Fund Administration, the only health care financing 
agency in Hungary. We analyzed the annual DRG based health insurance revenues 
with and without performance volume limit ceiling. We calculated the proportion 
of hospital activity over that ceiling measured by DRG cost-weights. The period 
2007-2013 was involved into the study. RESULTS: We found a significant loss in 
DRG reimbursement due to performance volume limit. The annual loss in DRG 
reimbursement varied between 2.4-10.5 million USD between 2007-2013. The highest 
revenue loss was observed in 2009, and after 2009 the financial loss decreased to 
7.0 (2010), 5.2 (2011), 3.0 (2012) and 2.8 (2013) million USD. This annual revenue loss 
represented 3.0-14.9 % of the annual revenues of the Clinical Centre of the University 
of Pécs. CONCLUSIONS: The introduction of performance volume limit into the 
DRG based hospital financing resulted in a partial loss of hospitals’ revenues. The 
Clinical Centre of the University of Pécs experienced significant loss its revenues 
due to this regulation.
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OBJECTIVES: Hospitalizations for Ambulatory Care Sensitive Conditions also known 
as preventable hospitalizations can be prevented by proper management in the 
primary care settings. West Virginia (WV) has highest per person preventable hospi-
talization cost as compared to other states. The objective of this study is to examine 
the rates of preventable hospitalizations and patient- and county-level factors that 
may be associated with preventable hospitalizations among Medicaid beneficiaries 
with chronic conditions in WV. METHODS: Longitudinal dynamic cohort design 
with baseline and follow-up years was used. Patient-level data were obtained from 
2007-2010 Medicaid claims files and county-level data were derived from the Area 
Health Resource File for WV. The study population included non-elderly inpatient 
users with selected chronic conditions and 24-months continuous fee-for-service 
enrollment in Medicaid and not enrolled in Medicare (n= 2,938). The dependent vari-
able was any preventable hospitalization in the follow-up year and these were iden-
tified using the Prevention Quality Indicator software developed by the Agency for 
Healthcare Research and Quality. All patient-level (e.g. demographic characteristics, 
healthcare utilization, and care continuity) and county-level factors (e.g. county level 
of healthcare infrastructure) were measured during the baseline. Chi-square tests 
and logistic regressions were used to determine the association between patient- 
and county-level factors and preventable hospitalizations. RESULTS: In this study 
population 65% were women, 96.3% were whites; 18.5% had any preventable hos-
pitalizations; 12.2% had chronic and 7.2% had acute preventable hospitalizations. 
A higher percentage of adults in the age group 35-44 had any preventable hospi-
talization (22.2%) compared to adults in the age-group 25-34 (14.0%). The results 
from multivariable analysis suggest that patients living in the counties with higher 
income were less likely to have acute preventable hospitalizations [AOR= 0.48, 95% 
CI (0.28, 0.83)]. CONCLUSIONS: Economic climate in WV counties may impact the 
risk of acute preventable hospitalizations.
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OBJECTIVES: The purpose of this study is to provide a source document in the 
creation of a dataset for analysis to develop a predictor algorithm for disease man-
agement. METHODS: A review of the literature was performed to determine best 
practices in the development of a dataset to design a predictor model. Algorithms 
improve applicability across health settings to meet various disease management 
aims. Peer reviewed articles and reports were retrieved from the published litera-
ture from 2004 to 2014. To summarize results a case study is also provided related 
to the need for a patient to enroll in a disease state management program based 
on predicting their chance to have a heart attack. RESULTS: Results revealed a 
total of 33 articles and reports. A summary of this information is provided as a 
step-by-step guide on how to setup a dataset to predict disease state management 
patient outcomes. The purpose of data collection should be discussed in detail 
(e.g. collection of data to identify high risk members). Using predictive modeling 
tools, data can be synthesized such as diagnoses, hospitalizations, emergency 
room encounters, expenditures and demographics to develop individualized risk 
profiles. The assessment period and outcomes of interest should be clearly defined 
followed by an analysis of model sensitivity and specificity. Members are assigned 
a chronic illness intensity index score based on these factors. Once scored, mem-
bers are filtered through clinical criteria that prioritize individuals with clinically 
manageable conditions. The resulting list represents those members with the 
most acute and complex illness burden. CONCLUSIONS: Findings from this study 
have implications for clinical care, patient outcomes, research, and policy. Many 
patients are not receiving appropriate preventive care, lack recommended care 
and receive contraindicated care. An increase in the creation of databases to be 
used effectively to develop predictor models is needed to intervene early in the 
disease cycle.
insulin was the predominant type and increased from 38% to 48% of patients 
taking insulin alone or combined with OADs. Patients without prescription claims 
for T2D medication dropped from 48% to 36%. Overall annual costs/T2D patient 
rose by $1466, from $13,743 to $15,175, adjusted to 2012 dollars. CONCLUSIONS: 
For patients in this database, T2D incidence rate decreased from 2007 to 2012, but 
increased pharmacy claims, comorbidity rates and resource utilization expanded 
the clinical and economic burden of managing T2D.
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OBJECTIVES: Approximately 36% of family caregivers help older adults man-
age medications. Caregivers have an extensive unmet need for information and 
training, however, the relationship between caregivers’ assistance in managing 
care-recipients’ medications and their use of training services is unclear. The 
objectives of this study are to examine the association between informal caregiv-
ers’ assistance in managing care-recipients’ medications and their a) receipt and 
b) initiation to seek caregiving-related training. METHODS: A retrospective non-
experimental study was conducted utilizing data from the National Health and 
Aging Trends Study (NHATS), and its supplement, the National Study of Caregiving 
(NSOC). NHATS is comprised of a nationally representative sample of Medicare 
beneficiaries (≥ 65 years) while NSOC includes a sample of their informal caregiv-
ers. Caregiver assistance in managing care-recipients’ medications was assessed 
using an item asking caregivers if they help keep track of care-recipients’ medica-
tions. Use of training services was assessed using two items asking if caregivers 
have received or looked for training to help provide care. Descriptive statistics 
and logistic regression were performed. RESULTS: Fifty four percent of caregiv-
ers (N= 1367) helped keep track of care-recipients’ medications. Approximately 
7% indicated they received training and 10.2% reported looking for training. After 
adjusting for caregivers’ education and gender and care-recipients’ gender, race, 
and number of chronic conditions, the adjusted odds of receiving training were 
2.58 (95% CI: 1.42, 4.69) fold higher for caregivers who kept track of medications. 
The adjusted odds of seeking training were 2.29 (95% CI: 1.36, 3.86) fold higher 
for caregivers who kept track. CONCLUSIONS: Results suggest that relatively few 
caregivers receive or seek training, however, caregivers who manage medications 
are more likely to have training for their care. Future research should examine the 
nature of training and how it impacts caregivers’ ability to manage medications.
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OBJECTIVES: We sought to determine whether admission rates (as a marker for 
more essential ED utilization) differed based on the type of outpatient provider 
contact patients experienced prior to their ED visits. METHODS: We performed a 
prospective, cross-sectional survey study of adult ED patients who presented to a 
single tertiary care referral center. Patients were asked whether they had attempted 
to contact healthcare providers prior to their visit, what type of provider, whether 
it was in person or by phone, and what instructions they received. Responses were 
matched with patient disposition. Those seen by a provider or told by phone to go 
the ED were considered “sent” to the ED. Others were considered “self-triaged.” 
Patients were considered to have had an “informed” decision to be sent to the ED if 
they were seen in person or spoke with a physician, as opposed to being sent by a 
nurse or office clerk. Pearson’s Chi-Square testing was used to determine associa-
tions between the type of outpatient provider contact and ED disposition. RESULTS: 
There was no difference in admission rate between those sent to the ED (86/166, 
51%) and those who self-triaged (134/292, 46%). Patients who received an informed 
decision to be sent to the ED were more likely to be admitted (59/99, 60%) than oth-
ers who were sent to the ED (23/61, 38%), p< 0.01. CONCLUSIONS: Patients directed 
to the ED by a physician were more likely to be admitted than those sent in by 
other ancillary staff. Admission rate might be one indicator of patient acuity. This 
indicates that a more informed decision to send patients to the ED may reduce 
avoidable ED utilization. Therefore, improving patients’ access to a physician by 
phone or expanding acute unscheduled care options for assessments may reduce 
ED visits that do not require hospital admission.
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